For: | Cao P, Chen Q, Shi CX, Wang LW, Gong ZJ. Sirtuin1 attenuates acute liver failure by reducing reactive oxygen species via hypoxia inducible factor 1α. World J Gastroenterol 2022; 28(17): 1798-1813 [PMID: 35633910 DOI: 10.3748/wjg.v28.i17.1798] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v28/i17/1798.htm |
Number | Citing Articles |
1 |
Long Li, Huimin Liu, Quanyou Chai, Junyi Wei, Yuqiao Qin, Jingyao Yang, He Liu, Jia Qi, Chunling Guo, Zhaoyang Lu. Dapagliflozin targets SGLT2/SIRT1 signaling to attenuate the osteogenic transdifferentiation of vascular smooth muscle cells. Cellular and Molecular Life Sciences 2024; 81(1) doi: 10.1007/s00018-024-05486-8
|
2 |
Hao Chen, Qianzhen Wu, Kaili Xuan, Wenqiang Guo, Kunfeng Zhang, Yuanyuan Wang, Zhenzhen Dai, Rong Sheng, Huaqi He, Yuzhe Huang, Yan Chen. Bioguided isolation, identification and bioactivity evaluation of anti-fatigue constituents from Schizophyllum commune. Fitoterapia 2024; 175: 105940 doi: 10.1016/j.fitote.2024.105940
|
3 |
Qi-Jun Wu, Tie-Ning Zhang, Huan-Huan Chen, Xue-Fei Yu, Jia-Le Lv, Yu-Yang Liu, Ya-Shu Liu, Gang Zheng, Jun-Qi Zhao, Yi-Fan Wei, Jing-Yi Guo, Fang-Hua Liu, Qing Chang, Yi-Xiao Zhang, Cai-Gang Liu, Yu-Hong Zhao. The sirtuin family in health and disease. Signal Transduction and Targeted Therapy 2022; 7(1) doi: 10.1038/s41392-022-01257-8
|
4 |
Zhong-Yuan Xing, Chuan-Jie Zhang, Li-Juan Liu. Targeting both ferroptosis and pyroptosis may represent potential therapies for acute liver failure. World Journal of Gastroenterology 2024; 30(33): 3791-3798 doi: 10.3748/wjg.v30.i33.3791
|